Kite, Trent
Mckenna, Abigail
Wegner, Rodney E.
Herbst, John
Karlovits, Stephen
John, David
Cote, David J.
Zada, Gabriel
Wei, Chris Z.
Taori, Suchet
Shastri, Neha
Lee, Cheng-Chia
Yang, Hua-Che
Mantziaris, Georgios
Tos, Salem M.
Benjamin, Carolina Gesteira
De Bonis, Alessandro
Passos, Gustavo
Ratnaparkhi, Anshul
Rivera, Cameron
Kılıç, Türker
Kılıç, Deniz
Düzkalir, Ali Haluk
Peker, Selcuk
Mathieu, David
Sheehan, Jason P.
Niranjan, Ajay
Lunsford, L. Dade
Shepard, Matthew J.
Article History
Received: 2 December 2025
Accepted: 12 January 2026
First Online: 29 January 2026
Declarations
:
: Institutional Review Board approval was obtained individually at each contributing site. Consent to participate varied across institutions but was generally not required given the retrospective nature of the study. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki. Not applicable.
: The following author, L. Dade Lunsford, M.D., is a stockholder of A.B. Elekta. Matthew J. Shepard is a consultant for GT Medical Technologies Inc. All other authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.